🇺🇸 FDA
Pipeline program

CT1812

COG1201

Phase 2 small_molecule completed

Quick answer

CT1812 for Dementia With Lewy Bodies is a Phase 2 program (small_molecule) at COGNITION THERAPEUTICS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
COGNITION THERAPEUTICS INC
Indication
Dementia With Lewy Bodies
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials